APA

Kamatani N., Naoyuki K., Fujimori S., Shin F., Hada T., Toshikazu H., Hosoya T., Tatsuo H., Kohri K., Kenjiro K., Nakamura T., Toshitaka N., Ueda T., Takanori U., Yamamoto T., Tetsuya Y., Yamanaka H., Hisashi Y., Matsuzawa Y. & Yuji M. (20111201). An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study. : Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Chicago

Kamatani Naoyuki, Naoyuki Kamatani, Fujimori Shin, Shin Fujimori, Hada Toshikazu, Toshikazu Hada, Hosoya Tatsuo, Tatsuo Hosoya, Kohri Kenjiro, Kenjiro Kohri, Nakamura Toshitaka, Toshitaka Nakamura, Ueda Takanori, Takanori Ueda, Yamamoto Tetsuya, Tetsuya Yamamoto, Yamanaka Hisashi, Hisashi Yamanaka, Matsuzawa Yuji and Yuji Matsuzawa. 20111201. An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study. : Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Harvard

Kamatani N., Naoyuki K., Fujimori S., Shin F., Hada T., Toshikazu H., Hosoya T., Tatsuo H., Kohri K., Kenjiro K., Nakamura T., Toshitaka N., Ueda T., Takanori U., Yamamoto T., Tetsuya Y., Yamanaka H., Hisashi Y., Matsuzawa Y. and Yuji M. (20111201). An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study. : Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

MLA

Kamatani Naoyuki, Naoyuki Kamatani, Fujimori Shin, Shin Fujimori, Hada Toshikazu, Toshikazu Hada, Hosoya Tatsuo, Tatsuo Hosoya, Kohri Kenjiro, Kenjiro Kohri, Nakamura Toshitaka, Toshitaka Nakamura, Ueda Takanori, Takanori Ueda, Yamamoto Tetsuya, Tetsuya Yamamoto, Yamanaka Hisashi, Hisashi Yamanaka, Matsuzawa Yuji and Yuji Matsuzawa. An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study. : Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 20111201.